teclistamab,talquetamab,daratumumab
genmab,janssen
['multiplemyeloma', 'redirectt-1', 'janssen']
for us #hcps attending #eha2023, watch dr. maria-victoria mateos ( ) present first results from the phase 1b/2 redirectt-1 study of a dual combination of bcma and gprc5d bispecific antibodies in patients with relapsed/refractory #multiplemyeloma. 
Dedicated to sharing Janssen Oncology scientific communications for US HCPs. Account run by Janssen Global Services LLC. Review our Guidelines: https://t.co/uieWByQjn3.